Use of Traumatic Brain Injury Biomarkers after a Potentially Concussive Event BACKGROUND STRUCTURE TO SUPPORT OPTIMAL USE OF TBI BIOMARKER INITIAL EVALUATION RISK EVALUATION FOR BRAIN INJURY & INTRACRANIAL HEMORRHAGE HIGH RISK: DO NOT DELAY CARE FOR TBI WHOLE BLOOD BIOMARKER MODERATE RISK: TEST TBI WB BIOMARKERS BEFORE EVACUATION LOW RISK FOR TBI: NO RISK FACTORS PRESENT LOCATIONS WITH ON-SITE HEAD CT PRIMARY CONCUSSIVE BLAST SYMPTOMATIC TREATMENT OF MILD TBI PERFORMANCE IMPROVEMENT (PI) MONITORING REFERENCES APPENDIX A: CLINICAL ALGORITHM FOR TBI BLOOD BIOMARKERS USE APPENDIX B: DETAILED INFORMATION ON THE TBI WB BIOMARKER APPENDIX C: SUMMARY OF RESEARCH APPENDIX D: CLASS VIII MEDICAL MATERIEL APPENDIX E: TELEMEDICINE/TELECONSULTATION APPENDIX F: INFORMATION REGARDING OFF-LABEL USES IN CPGS DOWNLOAD CPG IN PDF